Diethylstilbestrol-Associated Vaginal Adenosis Followed by Clear Cell Adenocarcinoma

SUMMARYA young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fourteen months later, on routine follow-up, a small vaginal clear cell adenocarcinoma was recognized. She refused any therapy other than wide local excisi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecological pathology 1986-01, Vol.5 (4), p.362-370
Hauptverfasser: Sander, Rickie, Nuss, Robert C, Rhatigan, Ronald M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 370
container_issue 4
container_start_page 362
container_title International journal of gynecological pathology
container_volume 5
creator Sander, Rickie
Nuss, Robert C
Rhatigan, Ronald M
description SUMMARYA young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fourteen months later, on routine follow-up, a small vaginal clear cell adenocarcinoma was recognized. She refused any therapy other than wide local excision. She was seen intermittently for several years with no recurrence. Five and one-half years after initial diagnosis she was found to have multiple sites of clear cell adenocarcinoma in the upper third of the lateral and anterior vaginal walls. Cases of vaginal adenosis followed later by the development of clear cell adenocarcinoma (metachronous cases) are distinctly unusual. The authors have collected the other recorded cases in the literature or in the Registry for Research on Hormonal Transplacental Carcinogenesis and have attempted to compare these cases with the larger group of patients who present with clear cell adenocarcinoma and have associated vaginal adenosis (synchronous cases). The authors have found few differences between the two groups. Most of the differences can be accounted for by the close follow-up of patients with known vaginal adenosis. However, it has been noted that the location of the clear cell adenocarcinoma is apparently different in the two groups. The reasons for this apparent difference are briefly discussed.
doi_str_mv 10.1097/00004347-198612000-00008
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00004347_198612000_00008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3643169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3848-8af5dbe530635ab168dfe99107c1818fe0f7b7012414aa6fbfe81f55cd5f61093</originalsourceid><addsrcrecordid>eNp1kbtOwzAUhi0EKqXwCEgZWAM-dXzJWAUKSJVYCmvkODY1uHFlp6r69rg0dOMs1vkvZ_iMUAb4HnDJH3CaghQ8h1IwmKYtP0jiDI2BEpFzoHCOxnjKU4SVcImuYvzCGBgwPkIjwgqS9DFaPlrdr_Yu9tY1OvbBu3wWo1dW9rrNPuSn7aTLZq3ufLQxm3vn_C45zT6rnJYhq7QbfCWDsp1fy2t0YaSL-mZ4J-h9_rSsXvLF2_NrNVvkiohC5EIa2jaaEswIlQ0w0RpdloC5AgHCaGx4wzFMCyikZKYxWoChVLXUsISBTJA43lXBxxi0qTfBrmXY14DrA6f6j1N94vQriVS9PVY322at21NxAJP8u8GXUUlnguyUjaeYIFCWAlKsOMZ23vU6xG-33elQr7R0_ar-75fIDy9mf_o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Diethylstilbestrol-Associated Vaginal Adenosis Followed by Clear Cell Adenocarcinoma</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Sander, Rickie ; Nuss, Robert C ; Rhatigan, Ronald M</creator><creatorcontrib>Sander, Rickie ; Nuss, Robert C ; Rhatigan, Ronald M</creatorcontrib><description>SUMMARYA young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fourteen months later, on routine follow-up, a small vaginal clear cell adenocarcinoma was recognized. She refused any therapy other than wide local excision. She was seen intermittently for several years with no recurrence. Five and one-half years after initial diagnosis she was found to have multiple sites of clear cell adenocarcinoma in the upper third of the lateral and anterior vaginal walls. Cases of vaginal adenosis followed later by the development of clear cell adenocarcinoma (metachronous cases) are distinctly unusual. The authors have collected the other recorded cases in the literature or in the Registry for Research on Hormonal Transplacental Carcinogenesis and have attempted to compare these cases with the larger group of patients who present with clear cell adenocarcinoma and have associated vaginal adenosis (synchronous cases). The authors have found few differences between the two groups. Most of the differences can be accounted for by the close follow-up of patients with known vaginal adenosis. However, it has been noted that the location of the clear cell adenocarcinoma is apparently different in the two groups. The reasons for this apparent difference are briefly discussed.</description><identifier>ISSN: 0277-1691</identifier><identifier>EISSN: 1538-7151</identifier><identifier>DOI: 10.1097/00004347-198612000-00008</identifier><identifier>PMID: 3643169</identifier><identifier>CODEN: IJGPDR</identifier><language>eng</language><publisher>Philadelphia, PA: International Society of Gynecological Pathologists</publisher><subject>Adenocarcinoma - chemically induced ; Adenocarcinoma - pathology ; Adult ; Biological and medical sciences ; Diethylstilbestrol - adverse effects ; Drug toxicity and drugs side effects treatment ; Female ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Precancerous Conditions - chemically induced ; Pregnancy ; Prenatal Exposure Delayed Effects ; Toxicity: urogenital system ; Vaginal Diseases - pathology ; Vaginal Neoplasms - chemically induced</subject><ispartof>International journal of gynecological pathology, 1986-01, Vol.5 (4), p.362-370</ispartof><rights>1986International Society of Gynecological Pathologists</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3848-8af5dbe530635ab168dfe99107c1818fe0f7b7012414aa6fbfe81f55cd5f61093</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8319981$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3643169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sander, Rickie</creatorcontrib><creatorcontrib>Nuss, Robert C</creatorcontrib><creatorcontrib>Rhatigan, Ronald M</creatorcontrib><title>Diethylstilbestrol-Associated Vaginal Adenosis Followed by Clear Cell Adenocarcinoma</title><title>International journal of gynecological pathology</title><addtitle>Int J Gynecol Pathol</addtitle><description>SUMMARYA young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fourteen months later, on routine follow-up, a small vaginal clear cell adenocarcinoma was recognized. She refused any therapy other than wide local excision. She was seen intermittently for several years with no recurrence. Five and one-half years after initial diagnosis she was found to have multiple sites of clear cell adenocarcinoma in the upper third of the lateral and anterior vaginal walls. Cases of vaginal adenosis followed later by the development of clear cell adenocarcinoma (metachronous cases) are distinctly unusual. The authors have collected the other recorded cases in the literature or in the Registry for Research on Hormonal Transplacental Carcinogenesis and have attempted to compare these cases with the larger group of patients who present with clear cell adenocarcinoma and have associated vaginal adenosis (synchronous cases). The authors have found few differences between the two groups. Most of the differences can be accounted for by the close follow-up of patients with known vaginal adenosis. However, it has been noted that the location of the clear cell adenocarcinoma is apparently different in the two groups. The reasons for this apparent difference are briefly discussed.</description><subject>Adenocarcinoma - chemically induced</subject><subject>Adenocarcinoma - pathology</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Diethylstilbestrol - adverse effects</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Precancerous Conditions - chemically induced</subject><subject>Pregnancy</subject><subject>Prenatal Exposure Delayed Effects</subject><subject>Toxicity: urogenital system</subject><subject>Vaginal Diseases - pathology</subject><subject>Vaginal Neoplasms - chemically induced</subject><issn>0277-1691</issn><issn>1538-7151</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kbtOwzAUhi0EKqXwCEgZWAM-dXzJWAUKSJVYCmvkODY1uHFlp6r69rg0dOMs1vkvZ_iMUAb4HnDJH3CaghQ8h1IwmKYtP0jiDI2BEpFzoHCOxnjKU4SVcImuYvzCGBgwPkIjwgqS9DFaPlrdr_Yu9tY1OvbBu3wWo1dW9rrNPuSn7aTLZq3ufLQxm3vn_C45zT6rnJYhq7QbfCWDsp1fy2t0YaSL-mZ4J-h9_rSsXvLF2_NrNVvkiohC5EIa2jaaEswIlQ0w0RpdloC5AgHCaGx4wzFMCyikZKYxWoChVLXUsISBTJA43lXBxxi0qTfBrmXY14DrA6f6j1N94vQriVS9PVY322at21NxAJP8u8GXUUlnguyUjaeYIFCWAlKsOMZ23vU6xG-33elQr7R0_ar-75fIDy9mf_o</recordid><startdate>19860101</startdate><enddate>19860101</enddate><creator>Sander, Rickie</creator><creator>Nuss, Robert C</creator><creator>Rhatigan, Ronald M</creator><general>International Society of Gynecological Pathologists</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19860101</creationdate><title>Diethylstilbestrol-Associated Vaginal Adenosis Followed by Clear Cell Adenocarcinoma</title><author>Sander, Rickie ; Nuss, Robert C ; Rhatigan, Ronald M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3848-8af5dbe530635ab168dfe99107c1818fe0f7b7012414aa6fbfe81f55cd5f61093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adenocarcinoma - chemically induced</topic><topic>Adenocarcinoma - pathology</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Diethylstilbestrol - adverse effects</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Precancerous Conditions - chemically induced</topic><topic>Pregnancy</topic><topic>Prenatal Exposure Delayed Effects</topic><topic>Toxicity: urogenital system</topic><topic>Vaginal Diseases - pathology</topic><topic>Vaginal Neoplasms - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sander, Rickie</creatorcontrib><creatorcontrib>Nuss, Robert C</creatorcontrib><creatorcontrib>Rhatigan, Ronald M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>International journal of gynecological pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sander, Rickie</au><au>Nuss, Robert C</au><au>Rhatigan, Ronald M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diethylstilbestrol-Associated Vaginal Adenosis Followed by Clear Cell Adenocarcinoma</atitle><jtitle>International journal of gynecological pathology</jtitle><addtitle>Int J Gynecol Pathol</addtitle><date>1986-01-01</date><risdate>1986</risdate><volume>5</volume><issue>4</issue><spage>362</spage><epage>370</epage><pages>362-370</pages><issn>0277-1691</issn><eissn>1538-7151</eissn><coden>IJGPDR</coden><abstract>SUMMARYA young woman was examined because of a history of in utero exposure to diethylstilbestrol and was identified as having vaginal adenosis. Fourteen months later, on routine follow-up, a small vaginal clear cell adenocarcinoma was recognized. She refused any therapy other than wide local excision. She was seen intermittently for several years with no recurrence. Five and one-half years after initial diagnosis she was found to have multiple sites of clear cell adenocarcinoma in the upper third of the lateral and anterior vaginal walls. Cases of vaginal adenosis followed later by the development of clear cell adenocarcinoma (metachronous cases) are distinctly unusual. The authors have collected the other recorded cases in the literature or in the Registry for Research on Hormonal Transplacental Carcinogenesis and have attempted to compare these cases with the larger group of patients who present with clear cell adenocarcinoma and have associated vaginal adenosis (synchronous cases). The authors have found few differences between the two groups. Most of the differences can be accounted for by the close follow-up of patients with known vaginal adenosis. However, it has been noted that the location of the clear cell adenocarcinoma is apparently different in the two groups. The reasons for this apparent difference are briefly discussed.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>International Society of Gynecological Pathologists</pub><pmid>3643169</pmid><doi>10.1097/00004347-198612000-00008</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0277-1691
ispartof International journal of gynecological pathology, 1986-01, Vol.5 (4), p.362-370
issn 0277-1691
1538-7151
language eng
recordid cdi_crossref_primary_10_1097_00004347_198612000_00008
source MEDLINE; Journals@Ovid Complete
subjects Adenocarcinoma - chemically induced
Adenocarcinoma - pathology
Adult
Biological and medical sciences
Diethylstilbestrol - adverse effects
Drug toxicity and drugs side effects treatment
Female
Humans
Medical sciences
Pharmacology. Drug treatments
Precancerous Conditions - chemically induced
Pregnancy
Prenatal Exposure Delayed Effects
Toxicity: urogenital system
Vaginal Diseases - pathology
Vaginal Neoplasms - chemically induced
title Diethylstilbestrol-Associated Vaginal Adenosis Followed by Clear Cell Adenocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A27%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diethylstilbestrol-Associated%20Vaginal%20Adenosis%20Followed%20by%20Clear%20Cell%20Adenocarcinoma&rft.jtitle=International%20journal%20of%20gynecological%20pathology&rft.au=Sander,%20Rickie&rft.date=1986-01-01&rft.volume=5&rft.issue=4&rft.spage=362&rft.epage=370&rft.pages=362-370&rft.issn=0277-1691&rft.eissn=1538-7151&rft.coden=IJGPDR&rft_id=info:doi/10.1097/00004347-198612000-00008&rft_dat=%3Cpubmed_cross%3E3643169%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3643169&rfr_iscdi=true